MedTrace Logo

Prevention of Venous Obstruction After Implantation of Cardiac Pacemaker and Defibrillator

NCT02331511 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2015-10-29

No results posted yet for this study

Summary

The purpose of this study is to determine whether Aspirin or Clopidogrel are effective in the prevention of venous obstruction after implantation of cardiac pacemaker or defibrillator.

Conditions

  • Complication of Cardiac Defibrillator
  • Disorder of Cardiac Pacemaker System
  • Venous Occlusion

Interventions

DRUG

placebo

placebo administration for 3 months after device(PPM,ICD,CRT) implantation

DRUG

Aspirin 80 mg daily

Aspirin 80 mg daily administration for 3 months after device(PPM,ICD,CRT) implantation

DRUG

Clopidogrel 75 mg daily

Clopidogrel administration for 3 months after device(PPM,ICD,CRT) implantation

Sponsors & Collaborators

  • Shahid Beheshti University of Medical Sciences

    lead OTHER

Principal Investigators

  • Morteza Saafi, M.D. · Shahid Beheshti University of Medical Sciences

  • Mohammad Ali Akbarzadeh, M.D. · Shahid Beheshti University of Medical Sciences

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-10-31
Primary Completion
2016-05-31
Completion
2016-06-30

Countries

  • Iran

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02331511 on ClinicalTrials.gov